Knowledge and practice of community pharmacists towards SGLT2 inhibitors [version 2; peer review: 3 approved]
Background: Sodium/glucose cotransporter 2 (SGLT2) inhibitors are a new class of oral anti-diabetic drugs which improve glycaemic control in type 2 diabetes mellitus (T2DM) by preventing the kidney from reabsorbing glucose back to blood. Community pharmacists have long-term relationships with most o...
| Main Authors: | , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
F1000 Research Ltd
2022-06-01
|
| Series: | F1000Research |
| Subjects: | |
| Online Access: | https://f1000research.com/articles/11-659/v2 |
| _version_ | 1818503758927101952 |
|---|---|
| author | Omar Gammoh Manar Alajarmeh Elaf Yousef Majd Abu Gneam Roaa Alnajjar Esam Qnais Mohammed Wedyan Muna Oqal Ahmad Al-Samdi Abdelrahim Alqudah |
| author_facet | Omar Gammoh Manar Alajarmeh Elaf Yousef Majd Abu Gneam Roaa Alnajjar Esam Qnais Mohammed Wedyan Muna Oqal Ahmad Al-Samdi Abdelrahim Alqudah |
| author_sort | Omar Gammoh |
| collection | DOAJ |
| description | Background: Sodium/glucose cotransporter 2 (SGLT2) inhibitors are a new class of oral anti-diabetic drugs which improve glycaemic control in type 2 diabetes mellitus (T2DM) by preventing the kidney from reabsorbing glucose back to blood. Community pharmacists have long-term relationships with most of their chronic patients, so they play a key role in care for people with diabetes. Therefore, the objective of this study was to assess pharmacists’ knowledge and practice towards SGLT2 inhibitors. Thus, improving pharmacists’ knowledge about this group of medications could improve the treatment outcome of people with diabetes. Methods: A cross-sectional study was conducted to meet the study objectives. A convenience sample of 348 community pharmacists in Jordan was recruited. knowledge and practice were assessed using a self-administered questionnaire created for the purpose of this study. Results: A total of 400 community pharmacists were reached, of whom 348 answered the survey (response rate 87%). The results indicated that SGLT2 inhibitors knowledge score among community pharmacists in Jordan was 6.61 (out of 12). Factors like age, gender, location of the pharmacy, years of pharmacists’ experience had no effect on knowledge score; however, pharmacists who attended training courses on diabetes had higher knowledge scores. Additionally, pharmacists’ dispensing practice toward SGLT2 inhibitors had insufficient knowledge, such as lack of knowledge about the superiority of SGLT2 inhibitors over other anti-diabetics and inability to give the best advice to patients. Conclusions: Our findings reflect a moderate knowledge among community pharmacists about SGLT2 inhibitors which may negatively affect the patients’ outcome; thus, continuous education for the pharmacists is essential. |
| first_indexed | 2024-12-10T21:28:14Z |
| format | Article |
| id | doaj.art-5e5bd050c58d438096f39656eef20046 |
| institution | Directory Open Access Journal |
| issn | 2046-1402 |
| language | English |
| last_indexed | 2024-12-10T21:28:14Z |
| publishDate | 2022-06-01 |
| publisher | F1000 Research Ltd |
| record_format | Article |
| series | F1000Research |
| spelling | doaj.art-5e5bd050c58d438096f39656eef200462022-12-22T01:32:55ZengF1000 Research LtdF1000Research2046-14022022-06-0111135641Knowledge and practice of community pharmacists towards SGLT2 inhibitors [version 2; peer review: 3 approved]Omar Gammoh0Manar Alajarmeh1Elaf Yousef2Majd Abu Gneam3https://orcid.org/0000-0001-8635-3920Roaa Alnajjar4Esam Qnais5Mohammed Wedyan6https://orcid.org/0000-0002-8693-5506Muna Oqal7Ahmad Al-Samdi8Abdelrahim Alqudah9https://orcid.org/0000-0003-3721-8225Department of Clinical Pharmacy and Pharmacy Practice, Yarmouk University, Irbid, Zarqa, 13133, JordanDepartment of clinical pharmacy and pharmacy practice, Faculty of pharmaceutical sciences, The Hashemite University, Zarqa, Zarqa, P.O box 330127, Zarqa 13133, Jordan, JordanDepartment of clinical pharmacy and pharmacy practice, Faculty of pharmaceutical sciences, The Hashemite University, Zarqa, Zarqa, P.O box 330127, Zarqa 13133, Jordan, JordanDepartment of clinical pharmacy and pharmacy practice, Faculty of pharmaceutical sciences, The Hashemite University, Zarqa, Zarqa, P.O box 330127, Zarqa 13133, Jordan, JordanDepartment of clinical pharmacy and pharmacy practice, Faculty of pharmaceutical sciences, The Hashemite University, Zarqa, Zarqa, P.O box 330127, Zarqa 13133, Jordan, JordanDepartment of Biology and Biotechnology, Faculty of Science, Hashemite University, Zarqa, Zarqa, 13133, JordanDepartment of Biology and Biotechnology, Faculty of Science, Hashemite University, Zarqa, Zarqa, 13133, JordanDepartment of Pharmaceutics and Pharmaceutical Technology, Faculty of Pharmaceutical sciences, The Hashemite University, Zarqa, Zarqa, 13133, JordanDepartment of Adult Health Nursing, Princess Salma Faculty of Nursing, Al al-Bayt University, Al-Mafraq, Zarqa, 13133, JordanDepartment of clinical pharmacy and pharmacy practice, Faculty of pharmaceutical sciences, The Hashemite University, Zarqa, Zarqa, P.O box 330127, Zarqa 13133, Jordan, JordanBackground: Sodium/glucose cotransporter 2 (SGLT2) inhibitors are a new class of oral anti-diabetic drugs which improve glycaemic control in type 2 diabetes mellitus (T2DM) by preventing the kidney from reabsorbing glucose back to blood. Community pharmacists have long-term relationships with most of their chronic patients, so they play a key role in care for people with diabetes. Therefore, the objective of this study was to assess pharmacists’ knowledge and practice towards SGLT2 inhibitors. Thus, improving pharmacists’ knowledge about this group of medications could improve the treatment outcome of people with diabetes. Methods: A cross-sectional study was conducted to meet the study objectives. A convenience sample of 348 community pharmacists in Jordan was recruited. knowledge and practice were assessed using a self-administered questionnaire created for the purpose of this study. Results: A total of 400 community pharmacists were reached, of whom 348 answered the survey (response rate 87%). The results indicated that SGLT2 inhibitors knowledge score among community pharmacists in Jordan was 6.61 (out of 12). Factors like age, gender, location of the pharmacy, years of pharmacists’ experience had no effect on knowledge score; however, pharmacists who attended training courses on diabetes had higher knowledge scores. Additionally, pharmacists’ dispensing practice toward SGLT2 inhibitors had insufficient knowledge, such as lack of knowledge about the superiority of SGLT2 inhibitors over other anti-diabetics and inability to give the best advice to patients. Conclusions: Our findings reflect a moderate knowledge among community pharmacists about SGLT2 inhibitors which may negatively affect the patients’ outcome; thus, continuous education for the pharmacists is essential.https://f1000research.com/articles/11-659/v2Diabetes SGLT2 inhibitors Pharmacists Jordaneng |
| spellingShingle | Omar Gammoh Manar Alajarmeh Elaf Yousef Majd Abu Gneam Roaa Alnajjar Esam Qnais Mohammed Wedyan Muna Oqal Ahmad Al-Samdi Abdelrahim Alqudah Knowledge and practice of community pharmacists towards SGLT2 inhibitors [version 2; peer review: 3 approved] F1000Research Diabetes SGLT2 inhibitors Pharmacists Jordan eng |
| title | Knowledge and practice of community pharmacists towards SGLT2 inhibitors [version 2; peer review: 3 approved] |
| title_full | Knowledge and practice of community pharmacists towards SGLT2 inhibitors [version 2; peer review: 3 approved] |
| title_fullStr | Knowledge and practice of community pharmacists towards SGLT2 inhibitors [version 2; peer review: 3 approved] |
| title_full_unstemmed | Knowledge and practice of community pharmacists towards SGLT2 inhibitors [version 2; peer review: 3 approved] |
| title_short | Knowledge and practice of community pharmacists towards SGLT2 inhibitors [version 2; peer review: 3 approved] |
| title_sort | knowledge and practice of community pharmacists towards sglt2 inhibitors version 2 peer review 3 approved |
| topic | Diabetes SGLT2 inhibitors Pharmacists Jordan eng |
| url | https://f1000research.com/articles/11-659/v2 |
| work_keys_str_mv | AT omargammoh knowledgeandpracticeofcommunitypharmaciststowardssglt2inhibitorsversion2peerreview3approved AT manaralajarmeh knowledgeandpracticeofcommunitypharmaciststowardssglt2inhibitorsversion2peerreview3approved AT elafyousef knowledgeandpracticeofcommunitypharmaciststowardssglt2inhibitorsversion2peerreview3approved AT majdabugneam knowledgeandpracticeofcommunitypharmaciststowardssglt2inhibitorsversion2peerreview3approved AT roaaalnajjar knowledgeandpracticeofcommunitypharmaciststowardssglt2inhibitorsversion2peerreview3approved AT esamqnais knowledgeandpracticeofcommunitypharmaciststowardssglt2inhibitorsversion2peerreview3approved AT mohammedwedyan knowledgeandpracticeofcommunitypharmaciststowardssglt2inhibitorsversion2peerreview3approved AT munaoqal knowledgeandpracticeofcommunitypharmaciststowardssglt2inhibitorsversion2peerreview3approved AT ahmadalsamdi knowledgeandpracticeofcommunitypharmaciststowardssglt2inhibitorsversion2peerreview3approved AT abdelrahimalqudah knowledgeandpracticeofcommunitypharmaciststowardssglt2inhibitorsversion2peerreview3approved |